Literature DB >> 28183227

Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment.

Chih-Feng Yen1,2,3, S Joseph Huang4,5, Chyi-Long Lee2,6, Hsin-Shih Wang1,2,3, Shuen-Kuei Liao2,7.   

Abstract

Adenomyosis, which manifests with focally or diffusely scattered endometrial tissue within the uterine myometrium, is an endometriosis-like disease with controversial pathogenesis and compromised reproductive outcomes. This review, including the in vitro and in vivo studies performed on human or mouse models, is aimed to summarize the specific molecular characteristics of endometrium in the biochemical microenvironments of uterine adenomyosis. Many studies attributed the endometrium as the main cause of pathogenesis, with evidence of differential genetic expression and/or epigenetic modulation as well as estrogen-induced epithelial-mesenchymal transition. However, some studies indicated that the myometrium could play a role in the development of disease, based on findings of smooth muscle metaplasia and/or fibroblast-to-myofibroblast transdifferentiation by the influence of local biochemical factors. To date, it remains unclear whether adenomyosis is a genetically determined or a microenvironmentally induced disorder or whether the dysregulation of local factors may elicit the alteration of genetic expression in the endometrium. Similarly, it is uncertain whether the endometrial characteristics would remain consistent or could change along with a woman's reproductive life. Further longitudinal studies of the epigenetic controls or system biology are needed to elucidate the pathogenesis. Discovery of effective conservative treatments to improve the reproductive outcomes of patients with adenomyosis is still warranted.

Entities:  

Keywords:  adenomyosis; endometriosis; endometrium; infertility; myometrium

Mesh:

Year:  2017        PMID: 28183227     DOI: 10.1177/1933719117691141

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  13 in total

1.  Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Authors:  Xin Wu; Vanida A Serna; Justin Thomas; Wenan Qiang; Michael L Blumenfeld; Takeshi Kurita
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

2.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

3.  Animal Models of Adenomyosis.

Authors:  Ryan M Marquardt; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  Semin Reprod Med       Date:  2020-10-26       Impact factor: 1.303

4.  Quercetin Inhibits Adenomyosis by Attenuating Cell Proliferation, Migration and Invasion of Ectopic Endometrial Stromal Cells.

Authors:  Wenbin Xu; Yizuo Song; Kehan Li; Biyun Zhang; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2020-09-21       Impact factor: 4.162

5.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

Review 6.  Epidemiologic Factors Associated with Endometriosis in East Asia.

Authors:  Chih-Feng Yen; Mee-Ran Kim; Chyi-Long Lee
Journal:  Gynecol Minim Invasive Ther       Date:  2019-01-23

Review 7.  Recent advances in understanding and managing adenomyosis.

Authors:  Silvia Vannuccini; Felice Petraglia
Journal:  F1000Res       Date:  2019-03-13

8.  Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology.

Authors:  Yuqian Xiang; Yabing Sun; Bingxin Yang; Yeping Yang; Ying Zhang; Tiantian Yu; Hefeng Huang; Junyu Zhang; Hong Xu
Journal:  J Cell Mol Med       Date:  2019-10-01       Impact factor: 5.310

9.  The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis.

Authors:  Shin Young Kim; Hye Min Moon; Min Kyoung Lee; Youn Jee Chung; Jae Yen Song; Hyun Hee Cho; Mee Ran Kim; Jang Heub Kim
Journal:  Obstet Gynecol Sci       Date:  2017-12-21

10.  Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis.

Authors:  Xue Shen; Hua Duan; Sha Wang; Lu Gan; Qian Xu; Jin-Jiao Li
Journal:  Biomed Res Int       Date:  2019-01-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.